Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Exp Eye Res ; 85(4): 462-72, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17765224

RESUMO

Reactive oxygen species (ROS) generated during inflammation are believed to play critical roles in various ocular diseases. However, the underlying mechanisms remain poorly understood. We investigated if pro-inflammatory cytokines, tumor necrosis factor (TNF)-alpha, interleukin-1 beta (IL-1 beta), and interferon-gamma (IFN-gamma), induce ROS in human retinal pigment epithelial (RPE) cells. TNF-alpha, IL-1 beta and IFN-gamma increased both intracellular and extracellular ROS production in a time- and dose-dependent manner. Thenoyltrifluoroacetone (TTFA), an inhibitor of mitochondrial respiratory chain, blocked TNF-alpha- and IFN-gamma-, but not IL-1 beta-induced ROS, whereas other two mitochondrial respiratory chain inhibitors, rotenone and antimycin A, had no effect. NADPH oxidase inhibitor (diphenylene iodinium) abolished the ROS production induced by IL-1 beta or IFN-gamma, but not by TNF-alpha, whereas 6-aminonicotinamide (6AN), an inhibitor of the hexose monophosphate shunt (HMS), had no significant effects on the ROS induced by all three cytokines. ROS scavengers, pyrrolidinedithiocarbamate (PDTC) and N-acetyl-cysteine (NAC), reduced the levels of ROS induced by TNF-alpha, IL-1 beta and IFN-gamma (P<0.05). Collectively, these results demonstrate that TNF-alpha, IL-1 beta and IFN-gamma increase mitochondrial- and NADPH oxidase-generated ROS in human RPE cells.


Assuntos
Citocinas/farmacologia , Mediadores da Inflamação/farmacologia , Epitélio Pigmentado Ocular/efeitos dos fármacos , Espécies Reativas de Oxigênio/metabolismo , Células Cultivadas , Relação Dose-Resposta a Droga , Transporte de Elétrons/efeitos dos fármacos , Transporte de Elétrons/fisiologia , Inibidores Enzimáticos/farmacologia , Humanos , Peróxido de Hidrogênio/metabolismo , Interferon gama/farmacologia , Interleucina-1beta/farmacologia , Mitocôndrias/fisiologia , NADPH Oxidases/antagonistas & inibidores , NADPH Oxidases/metabolismo , Oniocompostos/farmacologia , Epitélio Pigmentado Ocular/citologia , Epitélio Pigmentado Ocular/metabolismo , Proteínas Recombinantes/farmacologia , Fator de Necrose Tumoral alfa/farmacologia
2.
J Appl Toxicol ; 26(2): 126-31, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16252256

RESUMO

Airway instillation into rats of 2-chloroethyl ethyl sulfide (CEES), the half molecule of sulfur mustard compound, results in acute lung injury, as measured by the leak of plasma albumin into the lung. Morphologically, early changes in the lung include alveolar hemorrhage and fibrin deposition and the influx of neutrophils. Following lung contact with CEES, progressive accumulation of collagen occurred in the lung, followed by parenchymal collapse. The co-instillation with CEES of liposomes containing pegylated (PEG)-catalase (CAT), PEG-superoxide dismutase (SOD), or the combination, greatly attenuated the development of lung injury. Likewise, the co-instillation of liposomes containing the reducing agents, N-acetylcysteine (NAC), glutathione (GSH), or resveratrol (RES), significantly reduced acute lung injury. The combination of complement depletion and airway instillation of liposomes containing anti-oxidant compounds maximally attenuated CEES-induced lung injury by nearly 80%. Delayed airway instillation of anti-oxidant-containing liposomes (containing NAC or GSH, or the combination) significantly diminished lung injury even when instillation was delayed as long as 1 h after lung exposure to CEES. These data indicate that CEES-induced injury of rat lungs can be substantially diminished by the presence of reducing agents or anti-oxidant enzymes delivered via liposomes.


Assuntos
Substâncias para a Guerra Química/intoxicação , Pneumopatias/induzido quimicamente , Pneumopatias/prevenção & controle , Gás de Mostarda/análogos & derivados , Doença Aguda , Animais , Antioxidantes/administração & dosagem , Antioxidantes/uso terapêutico , Catalase/administração & dosagem , Catalase/uso terapêutico , Proteínas do Sistema Complemento/fisiologia , Sistemas de Liberação de Medicamentos , Terapia Enzimática , Enzimas/administração & dosagem , Lipossomos , Pulmão/patologia , Pneumopatias/patologia , Masculino , Gás de Mostarda/intoxicação , Ratos , Ratos Long-Evans , Substâncias Redutoras/administração & dosagem , Substâncias Redutoras/uso terapêutico , Superóxido Dismutase/administração & dosagem , Superóxido Dismutase/uso terapêutico
3.
J Appl Toxicol ; 22(4): 257-62, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12210543

RESUMO

The chemical warfare agent analog, 2-chloroethyl ethyl sulfide, known as 'half-mustard gas' (HMG), is less toxic and less of an environmental hazard than the full molecule and has been shown to produce an acute lung injury in rats when instilled via intrapulmonary injection. This injury is characterized by massive, localized hemorrhage and edema into the alveolar compartment and can be quantitated by measuring extravasation of (125)I-bovine serum albumin into the extravascular compartment. Employing this rat model of HMG-induced lung injury, we observed significant attenuation of the pulmonary injury when experimental animals were complement or neutrophil depleted prior to HMG challenge. Significant protection also was provided by the use of antioxidants such as catalase, dimethyl sulfoxide, dimethyl thiourea, resveratrol and N-acetyl-L-cysteine (NAC). The last compound showed protection from lung injury as high as 70% and was still effective even when given up to 90 min after exposure of the lungs to HMG. These data suggest that acute lung injury caused by exposure to HMG may be related partially to complement mediated pathways and the generation by neutrophils of toxic oxygen species The data indicate that NAC is an effective antidote against HMG-induced acute lung injury in the rat.


Assuntos
Antioxidantes/uso terapêutico , Gás de Mostarda/análogos & derivados , Gás de Mostarda/toxicidade , Síndrome do Desconforto Respiratório/prevenção & controle , Animais , Antioxidantes/administração & dosagem , Proteínas do Sistema Complemento/deficiência , Proteínas do Sistema Complemento/efeitos dos fármacos , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Venenos Elapídicos/farmacologia , Injeções Intraperitoneais , Intubação Intratraqueal , Pulmão/efeitos dos fármacos , Pulmão/patologia , Masculino , Gás de Mostarda/administração & dosagem , Neutropenia/imunologia , Neutrófilos/imunologia , Ratos , Ratos Long-Evans , Síndrome do Desconforto Respiratório/induzido quimicamente , Síndrome do Desconforto Respiratório/patologia , Organismos Livres de Patógenos Específicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA